Genzyme
LUMIZYME
Manufacturer:
Genzyme
Name:
LUMIZYME
HCPCS Code Descriptor:
Injection, alglucosidase alfa, (lumizyme), 10 mg
Category:
J Code
HCPCS:
J0221
NDC(s):
58468-0160-01
Primary Type:
Enzyme Replacement Therapy
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
LUMIZYME is an Enzyme Replacement Therapy drug manufactured by Genzyme and administered via the Intravenous route of administration. The J Code: J0221 is aligned to the drug LUMIZYME.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/12
HCPCS Effective Date:
1/1/12
HCPCS Short Description:
Lumizyme injection
Billing and Coding Guide:
https://www.lumizyme.com/-/media/ems/conditions/rarediseases/brands/lumizyme-new/site-pdf/lz%20billing%20guide%20gzus_lumi_14_11_1203_v3_final.pdf
Patient Assistance:
Not Found